Showing results (491-500 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|April 28, 2005
Treatment of small intestine bacterial overgrowth and related symptoms by rifaximinMichele Di Stefano, Gino Roberto CorazzaChemotherapy|April 28, 2005
Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tractIva Pelosini, Carmelo ScarpignatoChemotherapy|January 5, 2007
Vinblastine, a chemotherapeutic drug, inhibits palmitoylation of tubulin in human leukemic lymphocytesJoan M Caron, Margot HerwoodChemotherapy|August 11, 2006
Cytotoxicity of docetaxel (Taxotere) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cellsElizabeth K Balcer-Kubiczek, Mona Attarpour, Jing Jiang, et al.Chemotherapy|August 11, 2006
Hepatocyte growth factor is a better indicator of therapeutic response than C-reactive protein within the first day of treatment in pneumoniaHossein Abednazari, Junyang Xu, Eva Millinger, et al.Chemotherapy|May 13, 2006
Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patientsPaolo Malacarne, Stefano Bergamasco, Carlo DonadioChemotherapy|May 13, 2006
DNA-spermine and DNA-lipid aggregate formation visualized by fluorescence correlation spectroscopyTeresa Kral, Marek Langner, Martin HofChemotherapy|May 6, 2006
Comparison of the manual Mycobacteria Growth Indicator tube and the Etest with the method of proportion for susceptibility testing of Mycobacterium tuberculosisE Fegou, E Jelastopulu, S Nicolaou, et al.Chemotherapy|May 6, 2006
Decreased phosphoactive ERKs and JNKs in Malachite-green-transformed Syrian hamster embryo fibroblasts are associated with increased phosphoactive p38 kinase: possible therapeutic importanceBipasha Bose, Rekha R Gour, Leena Motiwale, et al.Pageof 308